DOCMORRIS : Warburg Research reiterates its Buy rating
In his latest research note, analyst Michael Heider confirms his positive recommendation. The broker Warburg Research is keeping its Buy rating. The target price remains unchanged at CHF 100.
Stay updated with breaking news from Michael Heider. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In his latest research note, analyst Michael Heider confirms his positive recommendation. The broker Warburg Research is keeping its Buy rating. The target price remains unchanged at CHF 100.
In a research note published by Michael Heider, Warburg Research advises its customers to buy the stock. The target price is unchanged at EUR 25.
Already positive, the research from Warburg Research and its analyst Michael Heider still consider the stock as a Buy opportunity. The target price is unchanged at EUR 24.40.
Warburg Research analyst Michael Heider maintains his Buy rating on the stock. The target price is unchanged and still at EUR 93.
In a research note, Warburg Research analyst Michael Heider has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at EUR 24.